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ABSTRACT
Exposure to ultraviolet B (UVB) irradiation from
sunlight induces the upregulation of VEGF, a
potent angiogenic factor that is critical for
mediating angiogenesis-associated photodamage.
However, the molecular mechanisms related to
UVB-induced VEGF expression have not been
fully defined. Here, we demonstrate that one of
the catalytic subunits of the IiB kinase complex
(IKK), IKKa, plays a critical role in mediating UVB-
induced VEGF expression in mouse embryonic
fibroblasts (MEFs), which requires IKKa kinase
activity but is independent of IKKb, IKKc and the
transactivation of NF-iB. We further show that
the transcriptional factor AP-1 functions as the
downstream target of IKKa that is responsible
for VEGF induction under UVB exposure. Both
the accumulation of AP-1 component, c-Fos and
the transactivation of AP-1 by UVB require the
activated IKKa located within the nucleus.
Moreover, nuclear IKKa can associate with c-Fos
and recruit to the vegf promoter regions contain-
ing AP-1-responsive element and then trigger
phosphorylation of the promoter-bound histone
H3. Thus, our results have revealed a novel
independent role for IKKa in controlling VEGF ex-
pression during the cellular UVB response by
regulating the induction of the AP-1 component
and phosphorylating histone H3 to facilitate AP-1
transactivation. Targeting IKKa shows promise for
the prevention of UVB-induced angiogenesis and
the associated photodamage.
INTRODUCTION
Chronic exposure to solar UVB (280–320nm wavelengths)
irradiation is known to induce a variety of medical
problems, including photoaging and skin cancers (1–3).
Angiogenesis, the process of generating new capillary
blood vessels, contributes largely to UVB-induced skin
damage. It has been well demonstrated that UVB irradi-
ation may induce vascular hyperpermeability, dermal
blood vessel dilation and lead to an imbalance between
angiogenic factors and inhibitors in the skin. The
expression of vascular endothelial growth factor (VEGF),
the main angiogenic factor, is increased by UVB exposure,
which plays a critical role in mediating angiogenesis-
associated photodamage and carcinogenesis (4,5).
However, the molecular mechanisms related to UVB-
induced VEGF expression are still largely unknown.
The IkB kinase (IKK) complex plays a critical role in
the activation of the NF-kB pathway under physiological
and pathological conditions (6). The two catalytic
subunits of the IKK complex, IKKa and IKKb, share
structural similarity but trigger NF-kB activation by dif-
ferent mechanisms. IKKb is involved in the activation of
the canonical NF-kB pathway in response to inﬂam-
matory stimuli by inducing the phosphorylation and
degradation of the NF-kB inhibitor, I-kB, which can sub-
sequently release NF-kB and enable its nuclear transloca-
tion and activation; while IKKa plays a key role in
activating the non-canonical NF-kB pathway upon
B-cell activating factor (BAFF) or CD40 ligation by pro-
cessing the NF-kB2/p100 precursor to the p52 subunit (6).
Besides the NF-kB and I-kB proteins, IKKa and IKKb
also target a variety of other substrates and therefore are
involved in many physiological and pathological processes
through NF-kB-dependent as well as independent mech-
anisms (6–8). Moreover, some speciﬁcity occurs between
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are exclusively regulated by one kinase but not the other
(9–19).
Distinct IKKb-independent roles of IKKa in the regu-
lation of cell growth and immunity have been extensively
described in recent studies (9–19). These novel functions of
IKKa are mediated by the broad actions of its various
downstream substrates. For example, IKKa is reported
to phosphorylate histone H3 at certain NF-kB-dependent
promoters in response to cytokine stimulation, which is
critical for the optimal induction of the NF-kB-target
genes expression (9,10). Moreover, IKKa also contributes
to NF-kB transactivation by phosphorylating and
activating the coactivator CBP and thereby switching the
binding preference of CBP from p53 to NF-kB to favor
the induction of NF-kB-mediated gene expression (11).
In another report, IKKa is shown to be involved in dere-
pressing NF-kB activity by phosphorylating and removing
the corepressor SMRT from the chromatin, which facili-
tates NF-kB transcription (12,13). In contrast to these
positive actions, IKKa is also reported to restricts
NF-kB activation by triggering the turnover of NF-kB
subunits p65 and c-Rel or suppressing the DNA-binding
ability of p65 in response to inﬂammatory stimuli (14,15).
These results have thus provided multiple lines of evidence
for the speciﬁc roles of IKKa in the regulation of NF-kB
transactivation. Moreover, some unique functions of
IKKa that are unrelated to NF-kB activity have also
been reported. For example, the studies on IKKa-null
mice have revealed that IKKa is essential for the regula-
tion of keratinocyte differentiation and the development
of embryonic skin and skin cancers, which cannot be
compensated for by IKKb (16–18,20,21). In addition,
IKKa can independently mediate tumor metastasis by in-
hibiting the transcription of the metastasis suppressor,
Maspin (19). These results suggest that IKKa may play
a considerably larger role that may go far beyond its
well-known actions in the activation of the NF-kB
pathway (7).
In the current study, we deﬁne a novel role for IKKa in
mediating UVB-induced VEGF expression, which is inde-
pendent of IKKb, IKKg and NF-kB activities, while
eliciting c-Fos-dependent AP-1 transactivation. The estab-
lished function of IKKa in mediating the inﬂammatory
response to UVB exposure may provide a novel clue for
the prevention of UVB-induced photodamage.
MATERIALS AND METHODS
Cells, plasmids and reagents
The wild-type (WT), IKKb
 /–, IKKa
 /–, reconstituted
IKKa
 /–(IKKa) and IKKb-KM mouse embryonic ﬁbro-
blasts (MEFs), which are WT MEFs stably expressing the
kinase mutant of IKKb, have been described in previous
studies (22,23). Both the VEGF- and HRE-luciferase
reporter plasmids, in which the transcription of the
luciferase reporter gene is driven by either  3.0kb of the
vegf promoter or the HIF1a-responsive elements, were
provided by Dr Chuanshu Huang (New York
University, USA). The AP-1-luciferase reporter plasmid
was described in previous studies (23–25). The expression
plasmids containing the IkBa mutant (HA-IkBa-AA) and
the dominant-negative mutant of c-Jun (DN-c-Jun) have
been described in previous studies (24,26). All expression
plasmids for the IKKa mutants (including the deletion
mutants, IKKa-NLS, IKKa-KM), WT c-Fos and the
c-Fos mutant, c-Fos S32A were constructed by regular
polymerase chain reaction (PCR) to obtain the DNA frag-
ments. The details of the primers used for the construction
are available upon request. Mouse p52 siRNA was
ordered from Invitrogen-Life Technology (Beijing,
China). Mouse IKKg siRNA, mouse IKKa siRNA and
their control siRNAs were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). The antibodies against
phospho-c-Jun (Ser73), c-Jun, phospho-c-Fos (Ser32),
IKKa, IKKb, p53, p52, GFP and b-actin were purchased
from Cell Signaling Technology (Beverly, MA). The
antibodies against HIF1a, c-Fos, IKKg, HA and
GAPDH were obtained from Santa Cruz Biotechnology.
An anti-FLAG antibody was obtained from Sigma
(St Louis, MO, USA). The anti-phospho-IKKa (Ser176/
Ser180) antibody (07–837) was purchased from
Millipore/Upstate (Billerica, MA, USA). MG132 and
cyclohexamide (CHX) were purchased from Sigma
(St. Louis, MO).
UVB apparatus and cell exposure
The UVB light source (CL-1000M Midrange Ultraviolet
Crosslinker) was purchased from UVP Inc. (Upland, CA)
and emitted UVB light at a wavelength of 302nm. The
cells were pretreated and irradiated at the desired doses of
UVB irradiation as described previously (25–27).
Cell culture and transfection
Cl41 cells were maintained in modiﬁed Eagle’s medium
supplemented with 5% fetal bovine serum (FBS). All
MEFs were maintained in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% FBS. The transfections
were performed with the LipofectAMINE 2000 or
LipofectAMINE
TM RNAi MAX reagents (Life
Technologies, Inc., Rockville, MD) according to the
manufacturer’s instructions. To establish the stable trans-
fections, cultures were subjected to either G418 or
hygromycin B selection. The stable transfectants were
cultured in drug-free medium for at least two passages
before being subjected to the various experiments.
Luciferase reporter assay
Cells were transiently or stably transfected with the
luciferase reporter constructs. The luciferase activities
were tested as described previously (26).
Reverse transcription polymerase chain reaction (RT–
PCR)
Total RNA was extracted with TRIzol reagent
(Invitrogen, Carlsbad, CA, USA), and cDNAs were
synthesized with the ThermoScript
TM RT–PCR system
(Invitrogen, Carlsbad, CA, USA). To detect the induction
of vegf and c-fos transcription, the following
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primers to amplify the mouse vegf or c-fos cDNA: vegf:
50-caacatcaccatgcagatcatg-30 (forward) and 50-tcaccgcctt
ggcttgtcaca-30 (reverse) and c-fos: 50-ggtctcctccgtggccc
cat-30 (forward) and 50-cttgcaggcaggtcggtggg-30 (reverse).
Enzyme-linked immunosorbent assay (ELISA)
VEGF production in the cell culture supernatants was
quantiﬁed by a mouse VEGF immunoassay kit (R&D
Systems, Inc., Minneapolis, MN, USA). In short, the
cells were seeded in 24-well plates and cultured to 90–
100% conﬂuence. Cells were subjected to UVB exposure
and the supernatants were collected at the indicated time
points to detect the induction of VEGF production under
UVB irradiation.
Western blot assay
Cellular protein extracts were prepared with cell lysis
buffer (10mM Tris–HCl, pH 7.4, 1% SDS, 1mM
Na3VO4) and resolved by SDS–PAGE. The signals were
detected as described in our previous reports (22,23,25).
Construction of c-Fos shRNA expression plasmid and
the establishment of the WT/c-Fos shRNA stable
transfectants
The c-Fos shRNA expression plasmid was constructed
by using the GeneSuppressor system (Imgenex Co.,
San Diego, CA). The target sequence of the mouse
c-Fos shRNA was 50-gcggagacagatcaacttgaa-30. The con-
struct was transfected into WT MEFs, and stable trans-
fectants were established by G418 selection.
Immunoprecipitation
WT MEFs were incubated for 8h following UVB
exposure and lysed. Cell lysate was pre-cleared by incuba-
tion with protein A/G-agarose (Santa Cruz
Biotechnology) and then incubated with 2mg of anti-c-
Fos antibody overnight at 4 C. Then, 40ml of protein
A/G-agarose were added to the complexes and incubated
with agitation for another 1h at 4 C. The samples were
washed with the cell lysis buffer and subjected to the
western blot assay. For the co-IP experiment, FLAG-wt
IKKa or its mutant expression plasmids were transfected
into 293T cells together with the GFP-c-Fos expression
construct. Cell lysates were immunoprecipitated with an
anti-GFP antibody and then the immunoprecipitants were
subjected to the western blot assay with an anti-FLAG
antibody.
ChIP assay
ChIP assay was performed using an EZ ChIP kit (Upstate
Biotechnology) as described previously (25,27). To specif-
ically amplify the regions containing the putative
AP-1-responsive elements within the mouse VEGF
promoter, PCR was performed with the following pairs
of primers: Site A ( 616 to  606): 50-tcgtgccaacggtttg
aggag-30 (forward) and 50-tctgtctgtccgtcagcgc-30 (reverse);
Site D ( 2122 to  2115): 50-agaagatgaaccgtaagcctag-30
(forward) and 50-aggcccttgttcctcctgatc-30 (reverse); and
Site E ( 2900 to  2892): 50-gagggttgagaatcacagctg-30
(forward) and 50-ggatggctctcttgtagcag-30 (reverse). The fol-
lowing pair of ChIP primers was also designed to amplify
the region covering the third exon of the vegf gene and
was used as a negative control (NC) in this experiment.
NC: 50-gttcatggatgtctaccagcg-30 (forward) and 50-tgatgttgc
tctctgacgtgg-30 (reverse).
RESULTS
UVB induces VEGF expression in the MEFs
To determine the effects of UVB exposure on VEGF ex-
pression in the MEFs, a VEGF luciferase reporter plasmid
containing  3.0kb of the vegf promoter was transfected
into WT MEFs, and then the stable transfectants were
established. When these transfectants were exposed to dif-
ferent doses of UVB irradiation or a single dose of UVB
irradiation for different time periods, we found both a
dose- and time-dependent increase of vegf promoter-
dependent luciferase activities in the WT MEFs
(Figure 1A and B). The peak induction of VEGF expres-
sion can be observed upon 0.5kJ/m
2 of UVB irradiation
(Figure 1A). Under the same exposure conditions, the in-
ducible VEGF luciferase activity was detected at 6h after
irradiation and was sustained for 24h (Figure 1B).
Based on the alternative splicing of the eight coding
exons, vegf mRNA exists as several different isoforms,
of which, the vegf120, vegf164 and vegf188 isoforms are
predominantly expressed (28). To further conﬁrm the
results obtained from the luciferase reporter assay, we
analyzed the mRNA levels of the vegf isoforms in the
absence or presence of UVB exposure by an RT–PCR
assay. As shown in Figure 1C, the levels of vegf164 and
vegf120 were increased signiﬁcantly in response to UVB
exposure. Furthermore, ELISA assay showed that a
dramatic increase in VEGF production was observed in
the culture supernatants of the MEFs within 24h after
UVB exposure (Figure 1D). Therefore, these results
indicate that UVB effectively induces VEGF expression
in the MEFs.
IKKa is involved in VEGF induction upon UVB exposure
Data from our previous studies have demonstrated that
IKKa can speciﬁcally mediate UVB-induced G0/G1
growth arrest and the apoptotic response independent of
IKKb in MEFs [(26) and Li, Y. et al. unpublished data],
which indicates a speciﬁc role for IKKa in protecting
against photodamage by UVB irradiation. Therefore,
whether IKKa could mediate or protect against
angiogenesis-related photodamage via regulating VEGF
expression deserved further investigation. To this end,
the VEGF luciferase reporter plasmid was stably trans-
fected into the IKKa-null cells and then the induction
of the VEGF luciferase activity was detected after UVB
exposure. As shown in Figure 2A, we repeatedly observed
a signiﬁcant induction of the vegf promoter-dependent
luciferase activity in the WT MEFs, while this response
was suppressed in the IKKa
 /– MEFs under the same
conditions. ELISA assay further conﬁrmed that the induc-
tion of VEGF production in the IKKa
 /– MEFs was also
2942 Nucleic Acids Research, 2012,Vol.40, No. 7signiﬁcantly reduced compared with that in the WT cells
(Figure 2B). These results indicate that IKKa is involved
in UVB-induced VEGF expression in the MEFs.
To further conﬁrm that the impairment of VEGF in-
duction in the UVB-treated IKKa
 /– MEFs was indeed
due to the speciﬁc deﬁciency of ikk expression rather
than non-speciﬁc gene changes during the establishment
of the IKKa
 /– MEFs, we next detected whether VEGF
induction could be restored in IKKa-reconstituted
IKKa-null cells. As shown in Figure 2C and D,
re-introduction of the ikk gene into the IKKa
 /– MEFs
partially rescued the induction of VEGF expression. These
ﬁndings indicate that IKKa plays a critical role in
mediating UVB-induced VEGF expression in MEFs.
To clarify whether IKKa can exert a general effect on
the regulation of VEGF expression in the cellular UVB
response, we next detected the levels of VEGF induction
in the UVB-treated mouse epidermal cells, Cl41, in the
absence or presence of IKKa expression. We found
that knockdown of IKKa expression in Cl41 cells signiﬁ-
cantly inhibited VEGF induction upon UVB exposure
(Figure 2E). These data suggest that the role for IKKa
in regulating VEGF induction might be a general effect of
the UVB response.
To address whether IKKa kinase activity is required
for mediating VEGF induction in the UVB response,
we compared the induced VEGF expression in the
wt IKKa to that of the kinase mutant of IKKa
(IKKa-KM)-reconstituted IKKa
 /– cells. As shown in
Figure 2F, overexpression of IKKa-KM in the IKKa
 /–
cells failed to rescue the upregulation of VEGF expression
to similar levels as the wt IKKa. Therefore, we conclude
that IKKa kinase activity is required for the induction of
VEGF expression in response to UVB irradiation.
The role for IKKa in mediating VEGF induction is
independent of IKKb, IKKc and NF-iB activities
To clarify whether IKKa-dependent VEGF upregulation
upon UVB exposure is related to IKKb, IKKg and
NF-kB activities, we ﬁrst compared the induction of
VEGF expression in the WT and IKKb
 /– MEFs. As
shown in Figure 3A, the levels of VEGF induction were
similar in the UVB-treated WT and IKKb
 /– MEFs,
which excluded the involvement of IKKb in regulating
VEGF expression in the UVB response. Then we
investigated whether IKKg contributed to UVB-induced
VEGF expression by using IKKg siRNA. As shown in
Figure 3B, speciﬁc knockdown of IKKg expression in
the WT MEFs did not alter the induced expression of
VEGF. Furthermore, C-terminal deletion mutant of
IKKa with the defective IKKg-binding domain rescued
VEGF induction in the IKKa-null cells to a comparable
level as the WT IKKa did (Supplementary Figure S1B).
These results indicate that IKKg is not involved in VEGF
induction upon UVB exposure, either. Next, we detected
Figure 1. UVB irradiation induces VEGF expression in MEFs. (A and B) A VEGF promoter-driven luciferase reporter plasmid was transfected into
WT MEFs, and stable transfectants were established. The cells were exposed to different doses of UVB (A) or a single dose of UVB (0.5kJ/m
2)
(B), and then VEGF luciferase activities were detected at 12h (A) or the indicated time points (B) after UVB exposure. (C) WT MEFs were left
untreated or treated with UVB irradiation (0.5kJ/m
2), and then the expression of vegf mRNAs were detected by an RT–PCR assay at the indicated
time points after UVB exposure. (D) WT MEFs were exposed to UVB irradiation (0.5kJ/m
2), and then the production of VEGF in the culture
supernatants was determined by ELISA at the indicated time points after UVB exposure.
Nucleic Acids Research,2012, Vol.40, No. 7 2943VEGF expression in the WT MEFs overexpressing
IkBa-AA, an IkBa mutant which can block IkBa degrad-
ation and the classical NF-kB pathway activation in
response to a variety of stimuli including UVB irradiation
(26,29). As shown in Figure 3C, overexpression of
IkBa-AA did not noticeably affect UVB-induced
upregulation of VEGF expression in the MEFs, indicating
that activation of the classical NF-kB pathway is not the
major signaling event that controls VEGF expression in
the UVB response. To further conﬁrm the above results,
we next detected the levels of VEGF induction in WT
MEFs stably transfected with the kinase mutant of
IKKb, IKKb-KM, which can speciﬁcally inhibit IKKb
and the downstream classical NF-kB pathway activation
as demonstrated in our previous studies (22,26). As
shown in Figure 3D, compared with the control
Figure 2. IKKa is required for UVB-induced VEGF expression. (A) WT and IKKa-null cells with the stable transfection of the VEGF
promoter-driven luciferase reporter plasmid were treated with different doses of UVB and then the VEGF luciferase activities were detected at
12h after UVB exposure. (B) WT and IKKa-null cells were exposed to UVB (0.5kJ/m
2) and then the production of VEGF in the culture super-
natants 24h after exposure was detected by ELISA. (C) The identiﬁcation of the reconstituted IKKa
 /–(IKKa) MEFs. (D) WT, IKKa
 /– and
IKKa
 /–(IKKa) cells were transiently transfected with a VEGF promoter-driven luciferase reporter plasmid and then exposed to UVB (0.5kJ/m
2).
Thirty-six hours after transfection, VEGF luciferase activities were detected at the indicated time points after UVB exposure. (E) Cl41 cells were
transfected with a VEGF promoter-driven luciferase reporter plasmid in combination with mouse IKKa siRNA or the control siRNA. Thirty-six
hours after transfection, the cells were subjected to UVB irradiation (0.5kJ/m
2) and the VEGF luciferase activities were detected at 12h after UVB
exposure. (F) IKKa-null cells were transfected with a VEGF promoter-driven luciferase reporter plasmid in combination with the control vector or
WT IKKa or IKKa-KM expression plasmids, respectively. The cells were subjected to UVB irradiation (0.5kJ/m
2) 36h after transfection, and the
VEGF luciferase activities were detected at 24h after UVB exposure.
2944 Nucleic Acids Research, 2012,Vol.40, No. 7Figure 3. The effect of IKKa in regulating UVB-induced VEGF expression is unrelated to IKKb, IKKg and NF-kB activities. (A) WT and IKKb
 /–
MEFs with a stable transfection of a VEGF promoter-driven luciferase reporter plasmid were treated with UVB (0.5kJ/m
2), and then the VEGF
luciferase activities were detected at the indicated time points after UVB exposure. (B) WT MEFs with a stable transfection of a VEGF
promoter-driven luciferase reporter plasmid were transfected with the mouse IKKg siRNA or its control siRNA and then subjected to UVB
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(continued)vector-transfected WT MEFs, ectopic overexpression of
IKKb-KM did not change the levels of VEGF induction
in response to UVB irradiation. Finally, to clarify whether
VEGF expression can be affected by changes in the acti-
vation status of the alternative NF-kB pathway, we
compared the levels of VEGF expression in WT MEFS
transfected with p52 siRNA or its control siRNA. As
shown in Figure 3E, no obvious changes in the VEGF
induction was observed in the presence or absence of
p52 expression, which indicate that UVB-induced VEGF
expression is unrelated to the activation status of the al-
ternative NF-kB pathway. Taken together, we conclude
from these data that the role for IKKa in upregulating
VEGF expression during UVB exposure is independent
of IKKb, IKKg and NF-kB activities.
UVB induces VEGF expression via an AP-1-dependent
and a HIF-1a-independent pathway
We next investigated the signaling pathway(s) by which
IKKa mediated the upregulation of VEGF expression in
the UVB response. It is well accepted that HIF1a plays a
critical role in inducing the transcription of vegf by
binding to the hypoxia response element (HRE) within
the vegf promoter in the tumor cells (30). However,
whether this type of inducible activity is involved in the
UVB-induced VEGF expression in the MEFs is unclear.
To answer this question, an HRE luciferase reporter
plasmid was introduced into WT MEFs and then the in-
duction of HRE-dependent luciferase activities in response
to UVB exposure was detected. As shown in Figure 4A,
we did not observe a notable induction of HRE-dependent
luciferase activity and the accumulation of HIF1a protein
in the WT MEFs exposed to the different doses of UVB
irradiation at the indicated time points. As a positive
control, NiCl2 effectively caused accumulation of HIF1a
and upregulation of vegf transcription in the same cells
(Figure 4B). These results suggest that HIF1a is not
involved in UVB-induced VEGF expression in the
UVB-treated MEFs.
Due to the multiple AP-1-binding sites within the vegf
promoter, we next speculated that AP-1 might be involved
in regulating UVB-induced VEGF expression. To address
this possibility, WT MEFs stably transfected with the
AP-1 luciferase reporter plasmid, were exposed to differ-
ent doses of UVB irradiation, and then the transactivation
of AP-1 was detected at the different time points after
UVB exposure. As shown in Figure 4C, UVB irradiation
could induce both a dose- and time-dependent increase
in AP-1 transactivation in the WT MEFs, which was
accompanied by a signiﬁcant phosphorylation of c-Jun
and an induction of c-Fos expression under the same con-
ditions (Figure 4D). However, no obvious changes in the
activation status or the expression levels of the other AP-1
components (JunD, FosB, Fra-1, ATF2) were observed
(data not shown). These results indicate that UVB
exposure induces transactivation of AP-1 mainly com-
prised of c-Jun and c-Fos.
Next, we tested the contribution of AP-1 activation to
VEGF expression upon UVB treatment. To this end, the
VEGF luciferase reporter plasmid was transiently
introduced into WT MEFs overexpressing DN-c-Jun,
which were established previously (23). As shown in
Figure 4E, DN-c-Jun overexpression signiﬁcantly in-
hibited the activation of c-Jun induced by UVB, while
VEGF induction was also greatly impaired under the
same conditions. Then, a c-Fos shRNA expression
plasmid was constructed and transfected into WT MEFs
to establish the stable c-Fos shRNA transfectants. We
found that UVB-induced c-Fos expression can be almost
completely blocked by transfection of c-Fos shRNA into
the WT MEFs. Under the same conditions, the inducible
expression of VEGF was signiﬁcantly inhibited compared
with that of the control shRNA-transfected cells
(Figure 4F). Taken together, these data indicate that
UVB irradiation induces VEGF expression through an
AP-1(c-Jun/c-Fos)-dependent while a HIF1a-independent
manner.
c-Fos functions as the key downstream target of IKKa
in regulating VEGF induction upon UVB exposure
To further investigate the functional link between IKKa
and AP-1 transactivation in the UVB-induced VEGF ex-
pression, we next compared the AP-1-dependent luciferase
activity in the WT and IKKa
 /– MEFs. We found that
UVB-induced AP-1 transactivation was almost completely
blocked by ikk deﬁciency (Figure 5A). Under the same
conditions, c-Jun phosphorylation was slightly reduced,
while the induction of c-Fos expression was entirely
absent in the IKKa
 /– MEFs (Figure 5B). These data sug-
gested that AP-1 functioned as a downstream target of
IKKa in the cellular UVB response and that the expres-
sion of one of the AP-1 components, c-Fos, is tightly
regulated by IKKa. To further conﬁrm these results, we
next detected the expression of c-Fos and AP-1 transacti-
vation in the reconstituted IKKa
 /–(IKKa) cells. As
shown in Figure 5C, reconstitution of IKKa efﬁciently
restored the strong induction of c-Fos expression in
response to UVB irradiation, which was accompanied by
a recovery of AP-1 transactivation, in the IKKa
 /–(IKKa)
cells (Figure 5D). These results indicate that c-Fos is the
Figure 3. Continued
irradiation 36h after transfection. The VEGF luciferase activities were detected at the indicated time points after UVB exposure. (C) The expression
plasmids containing HA-IkBa-AA or the control vector were transiently transfected into the WT MEFs that were stably transfected with a VEGF
promoter-driven luciferase reporter plasmid. The cells were exposed to UVB irradiation (0.5kJ/m
2) 36h after transfection, and the induction of
VEGF luciferase activities were detected at the indicated time points after UVB exposure. (D) A VEGF promoter-driven luciferase reporter plasmid
was transiently transfected into WT MEFs that were stably transfected with FLAG-IKKb-KM. The cells were exposed to UVB irradiation (0.5kJ/
m
2) 36h after transfection, and the induction of VEGF luciferase activities were detected at the indicated time points after UVB exposure. (E)W T
MEFs with a stable transfection of a VEGF promoter-driven luciferase reporter plasmid were transfected with the mouse p52 siRNA or its control
siRNA. The cells were subjected to UVB irradiation (0.5kJ/m
2) 36h after transfection, and the VEGF luciferase activities were detected at the
indicated time points after UVB exposure.
2946 Nucleic Acids Research, 2012,Vol.40, No. 7Figure 4. UVB irradiation induces VEGF expression via an AP-1-dependent and HIF1a-independent pathway. (A and B) An HRE luciferase
reporter plasmid was introduced into the WT MEFs and then the stable transfectants were established. The cells were exposed to different doses
of UVB (A) or NiCl2 (B), and then the induction of HRE-mediated luciferase activities was detected at 12 or 24h after stimulation. The levels of
HIF1a induction were detected under the same exposure conditions. (C) WT MEFs with the stable transfection of an AP-1 luciferase reporter
plasmid were exposed to different doses of UVB and the AP-1 luciferase activities were determined at the indicated time points after exposure. (D)
WT MEFs were exposed to different doses of UVB and the activation of c-Jun and the induction of c-Fos expression were detected at 12h after
UVB exposure. (E) WT MEFs that were stably transfected with the dominant-negative mutant of c-Jun (TAM67) or its control vector were exposed
to different doses of UVB irradiation, and then the activation of c-Jun was determined at 12h after UVB exposure. Then the VEGF luciferase
reporter plasmid was transiently transfected into WT/TAM67 MEFs and control cells. The cells were exposed to different doses of UVB irradiation
36h after transfection, and the induction of VEGF luciferase activities was detected at 12h after exposure. (F) WT MEFs were transfected with the
c-Fos shRNA or the control GFP shRNA and then the stable transfectants were established. The cells were exposed to different doses of UVB and
the induction of c-Fos was detected at 12h after UVB stimulation. Then, the VEGF luciferase reporter plasmid was transiently transfected into WT/
c-Fos shRNA MEFs or control cells. The cells were exposed to different doses of UVB irradiation 36h after transfection, and the induction of the
VEGF luciferase activities was detected at 12h after exposure.
Nucleic Acids Research,2012, Vol.40, No. 7 2947Figure 5. c-Fos functions as the key downstream target of IKKa in regulating VEGF induction upon UVB exposure. (A) WT and IKKa-null cells
with a stable transfection of the AP-1 luciferase reporter plasmid were treated with different doses of UVB and then the AP-1 luciferase activities
were detected at 12h after UVB exposure. (B) WT and IKKa-null cells were exposed to different doses of UVB and then the activation of c-Jun and
the expression of c-Fos were determined at 12h after UVB exposure. (C) IKKa
 /– and IKKa
 /–(IKKa) cells were exposed to UVB (0.5kJ/m
2) and
the induction of c-Fos was detected at the indicated time points after exposure. (D) An AP-1 luciferase reporter plasmid was transfected into WT,
IKKa
 /–and IKKa
 /–(IKKa) cells. The cells were subjected to UVB irradiation (0.5kJ/m
2) 36h after transfection, and then the AP-1 luciferase
activities were detected at the indicated time points after UVB exposure. (E) Cl41 cells were transfected with mouse IKKa siRNA or the control
siRNA and then subjected to UVB irradiation (0.5kJ/m
2) 36h after transfection. The induction of c-Fos expression was detected at the indicated
time points after UVB exposure. (F) Cl41 cells were transfected with the AP-1 luciferase reporter plasmid in combination with mouse IKKa siRNA
or the control siRNA, and then subjected to the UVB irradiation (0.5kJ/m
2) 36h after transfection. The AP-1 luciferase activities were detected at
12h after UVB exposure. (G) WT MEFs with a stable transfection of FLAG-IKKb-KM and the control cells were exposed to UVB (0.5kJ/m
2), and
then the induction of c-Fos expression was detected at 12h after UVB exposure. (H) WT MEFs were transfected with the mouse IKKg siRNA or its
control siRNA and then subjected to UVB irradiation (0.5kJ/m
2) 36h after transfection. The induction of c-Fos expression was detected at12h after
UVB exposure. (I) The HA-IkBa-AA expression plasmid or the control vector were transiently transfected into the WT MEFs. The cells were
exposed to UVB irradiation (0.5kJ/m
2) 36h after transfection, and then the induction of c-Fos expression was detected at 12h after UVB exposure.
(J) WT MEFs were transfected with a mouse p52 siRNA or its control siRNA and then subjected to UVB irradiation (0.5kJ/m
2) 36h after
transfection. The induction of c-Fos expression was detected at 12h after UVB exposure.
2948 Nucleic Acids Research, 2012,Vol.40, No. 7key downstream target of IKKa that comprises the
AP-1 heterodimer and regulates VEGF expression in
the UVB-treated ﬁbroblasts. We further proved that
JNKs were only responsible for UVB-induced c-Jun ac-
tivation, but not involved in c-Fos induction under the
same conditions (Supplementary Figure S2). Therefore,
it seems that JNKs and IKKa synergistically mediate
AP-1 transactivation via regulating c-Jun activation
and c-Fos induction respectively in the cellular UVB
response.
In the following experiments, we further found that
knocking down IKKa expression in the Cl41 cells can
also signiﬁcantly block c-Fos induction and AP-1 transac-
tivation upon UVB exposure (Figure 5E and F). These
results are consistent with the reduced VEGF induction
in the IKKa siRNA-transfected Cl41 cells (Figure 2E)
and suggest the general effect of IKKa in mediating
UVB-induced VEGF expression through a c-Fos/AP-1-
dependent pathway.
We next detected the roles for IKKb and IKKg in the
UVB-induced c-Fos expression. As shown in Figure 5G
and H, neither IKKb-KM overexpression nor IKKg
siRNA transfection could alter the levels of c-Fos induc-
tion upon UVB exposure. And the C-terminal deletion
mutant of IKKa with the defective IKKg-binding
domain efﬁciently rescued c-Fos induction in the
IKKa-null cells (Supplementary Figure S1A). These data
indicate that IKKa-mediated c-Fos expression is unre-
lated to IKKb and IKKg activities. To further address
whether NF-kB transactivation is involved in
UVB-induced c-Fos expression, we detected the changes
in the levels of c-Fos expression after the activation of the
classical or alternative NF-kB pathway was inhibited by
IkBa-AA or p52 siRNA, respectively. We found that
c-Fos induction was not affected by the changes in acti-
vation of either NF-kB pathway (Figure 5I and J).
Therefore, we conclude that the role for IKKa in
regulating c-Fos expression during UVB irradiation is un-
related to the activation status of the IKKb, IKKg and
NF-kB-dependent pathways, which is consistent with the
mechanism of VEGF induction under the same UVB
exposure conditions (Figure 2).
IKKa regulates N-terminal phosphorylation and protein
stabilization of c-Fos in the cellular UVB response
The induction of c-Fos expression can be regulated at
multiple levels (31–35). To clarify the mechanism
through which IKKa regulates c-Fos induction in the
cellular UVB response, we ﬁrst compared c-fos gene tran-
scription and the induction of c-Fos protein expression in
the WT and IKKa
 /– cells upon UVB exposure. As shown
in Figure 6A, although the increase in c-Fos protein ex-
pression was almost completely blocked by ikk deﬁ-
ciency, the induction of c-fos mRNA transcription did
not exhibit detectable differences between WT and
IKKa
 /– cells under the same UVB exposure conditions.
These ﬁndings suggest that UVB-induced c-Fos expression
might occur at a post-transcriptional level, most possibly
results from changes in its protein stability. To test this
hypothesis, WT and IKKa
 /– cells were pretreated with
MG132, an established proteasome inhibitor that disrupts
protein degradation, and then exposed to UVB irradi-
ation. As indicated in Figure 6B, pretreatment with
MG132 resulted in a signiﬁcant accumulation of c-Fos
protein in the UVB-irradiated IKKa
 /– cells. These
results demonstrate that IKKa is involved in increasing
c-Fos protein stability by actively blocking its degradation
via the proteasome in the cellular UVB response.
It has been well demonstrated that the turnover of c-Fos
proteins is tightly controlled by phosphorylation of the
serines and/or threonines located at both the N- and
C-termini (Ser32, Thr232 and Ser374) under various con-
ditions (31,32,36,37). Therefore, to address whether IKKa
regulates c-Fos protein stability via a phosphorylation-
dependent manner in the UVB response, we compared
the phosphorylation of c-Fos at the residues indicated
above in the WT and IKKa
 /– cells by using speciﬁc
anti-phospho-c-Fos antibodies. As shown in Figure 6C,
accompanied by a signiﬁcant increase in c-Fos expression,
UVB exposure could induce a strong phosphorylation at
Ser32 in the WT MEFs. However, this response was
almost completely blocked by ikk deﬁciency under the
same conditions. No detectable phosphorylation at the
other serine or threonine residues on c-Fos was observed
in the UVB-treated WT or IKKa
 /– cells (data not
shown). Furthermore, we found that although MG132
pretreatment efﬁciently accumulated c-Fos in the IKKa-
null cells, no induction of c-Fos phosphorylation at Ser32
was observed upon UVB irradiation without ikk gene
expression (Figure 6B). In Addition, re-introduction of
the WT ikk gene into the IKKa
 /– cells signiﬁcantly
restored the induced phosphorylation of c-Fos at Ser32,
which was accompanied by c-Fos expression, upon UVB
irradiation. However, these responses were not observed
in the IKKa-KM-reconstituted IKKa
 /– cells under the
same conditions (Figure 6D). These results indicate that
IKKa regulates c-Fos protein stability by inducing phos-
phorylation at its N-terminus.
To further conﬁrm the contribution of Ser32 phosphor-
ylation to the increased c-Fos protein stability in the UVB
response, WT c-Fos and its mutant c-Fos S32A expression
plasmids were constructed. Then we designed an experi-
mental system to analyze the effect of UVB exposure on
the degradation of wt c-Fos and c-Fos S32A. WT cells
transfected with wt c-Fos or c-Fos S32A were pre-treated
with MG132 and then exposed to the protein synthesis
inhibitor, CHX, for the different time periods in the
absence or presence of UVB irradiation after MG132
withdrawal. As shown in Figure 6E, MG132 pretreatment
can accumulate exogenous wt c-Fos and c-Fos S32A at a
comparable level. After withdrawal of MG132 and CHX
exposure, the pre-accumulated wt c-Fos and c-Fos S32A
showed similar time-dependent degradation dynamics in
the absence of UVB exposure. However, upon UVB ir-
radiation, wt c-Fos was more stable and its degradation
was signiﬁcantly inhibited, but c-Fos S32A degraded more
rapidly than wt c-Fos under the same UVB irradiation
conditions. These data suggest that IKKa-mediated
c-Fos phosphorylation at Ser32 protects this protein
from degradation via proteasome in the UVB response.
Nucleic Acids Research,2012, Vol.40, No. 7 2949UVB exposure induces phosphorylation of nuclear IKKa,
which can associate with c-Fos and recruit to the vegf
promoter to trigger the phosphorylation of
promoter-bound histone H3
Most of the speciﬁc roles for IKKa that are independent
of IKKb in the regulation of gene expression are related to
the features of nuclear localization or translocation of
IKKa (9,10,38,39). Therefore, in the following experi-
ments, we detected the nuclear/cytoplasmic distribution
of IKKa in the UVB-treated MEFs. We found that en-
dogenous IKKa predominantly accumulated in the cyto-
plasm of the MEFs with no obvious nuclear translocation
of IKKa detected after UVB exposure. However, the im-
munoblotting analysis with the anti-phospho-IKKa
antibody revealed that a nuclear pool of IKKa was
strongly phosphorylated upon UVB irradiation. Under
the same conditions, we also found an accumulation of
c-Fos in the nucleus (Figure 7A). Since IKKa kinase
activity is critical for mediating c-Fos induction (Figure
2F), we speculated that it might be the activated form of
IKKa located within the nucleus that was responsible for
the phosphorylation-dependent expression of c-Fos. To
test this possibility, IKKa bearing three point mutations
within the endogenous NLS (IKKa-NLS) was constructed
based upon a previously published report (40), and its
ability to mediate c-Fos expression under UVB irradiation
was detected. As expected, when WT IKKa and IKKa-
NLS were expressed at comparable levels in the
IKKa-null cells, IKKa-NLS was only found in the cyto-
plasm, whereas wt IKKa distributed in both the cyto-
plasm and nucleus (Supplementary Figure S3A). Under
these conditions, we observed a strong recovery of c-Fos
phosphorylation and expression in the wt IKKa-
reconstituted IKKa
 /– cells. All these responses were
Figure 6. IKKa regulates N-terminal phosphorylation and protein stabilization of c-Fos in the UVB response. (A) WT and IKKa
 /– cells were
exposed to UVB (0.5kJ/m
2), and the induction of c-fos mRNA transcription and protein expression were detected by RT–PCR and immunoblot
assay, respectively. (B) WT and IKKa
 /– cells were pretreated with MG132 (10mM) for 4h followed by exposure to UVB (0.5kJ/m
2). The induction
of c-Fos phosphorylation and expression was detected at 6h after UVB exposure. (C) WT and IKKa
 /– cells were exposed to UVB (0.5kJ/m
2), and
the induction of c-Fos phosphorylation and expression were detected at the indicated time points after UVB exposure. (D) IKKa-null cells were
transfected with the control vector, WT IKKa or IKKa-KM expression plasmids, respectively. The cells were subjected to UVB irradiation (0.5kJ/
m
2) 36h after transfection, and the induction of c-Fos phosphorylation and expression were detected at 12h after UVB exposure. (E) The expression
plasmids containing WT c-Fos and c-Fos S32A (with GFP tags) were constructed and transfected into WT MEFs, respectively. Twenty-four hours
after transfection, the cells were pretreated with MG132 (10mM) for 4h followed by exposure to CHX (10mM) at the indicated time periods in the
absence or presence of UVB irradiation (0.5kJ/m
2) after MG132 withdrawal. The degradation dynamics of c-Fos was detected with an anti-GFP
antibody.
2950 Nucleic Acids Research, 2012,Vol.40, No. 7Figure 7. UVB-induced histone H3 phosphorylation at the AP-1-responsive elements within the vegf promoter requires IKKa recruitment and
contributes largely to the UVB-induced VEGF expression. (A) WT MEFs were exposed to a single dose (0.5kJ/m
2) of UVB for the time indicated,
and then cytoplasmic and nuclear proteins were prepared. The subcellular distribution of c-Fos, IKKa and phosphorylated IKKa were detected by a
western blot assay. The expression of GAPDH and p53 were used as markers for cytoplasmic and nuclear extracts, respectively. (B) IKKa-null cells
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(continued)absent in the IKKa-NLS-transfected IKKa
 /– cells
(Figure 7B). Accordingly, VEGF induction was also in-
hibited in the IKKa-NLS-transfected IKKa
 /– cells
compared to that in the wt IKKa-reconstituted IKKa
 /–
cells (Supplementary Figure S3B). These ﬁndings thus
indicate that the nuclear localization of IKKa is critical
for mediating c-Fos induction and VEGF expression in
the UVB response.
Since the activated form of IKKa and the accumulated
c-Fos are colocalized within the nucleus, we wondered
whether these two proteins might function cooperatively.
To address this possibility, we ﬁrst detected the potential
interaction of p-IKKa with c-Fos by co-IP. As shown in
Figure 7C, p-IKKa was observed in the UVB-treated
c-Fos immunoprecipitates but not in the control IgG
and UVB-untreated groups. These results indicate that
UVB exposure can induce the accumulation of c-Fos
within the nucleus and trigger its interaction with the
nuclear IKKa. To clarify whether the interaction of
IKKa with c-Fos is required for c-Fos induction, several
IKKa C-terminal deletion mutants were constructed
(Figure 7D), and their ability to interact with c-Fos was
detected (the N-terminal kinase domain and NLS located
within this region are required for c-Fos induction, as
demonstrated in Figure 6D and Figure 7B). We found
that truncation of the C-terminal IKKg-binding domain
within IKKa (IKKa-M1) did not affect its ability to bind
c-Fos. However, further deletion of the regions containing
the HLH motif (IKKa-M2) and the LZ motif (IKKa-M3)
completely destroyed the interaction of IKKa with c-Fos
(Figure 7D). Interestingly, although showed a defective
c-Fos-binding ability, IKKa-M3 displayed a similar
activity in mediating c-Fos expression as the WT IKKa
did (Figure 7E). These data indicate that the role for
IKKa in mediating c-Fos expression does not require
the direct interaction between these two proteins.
So what the functional importance of the interaction
between IKKa and c-Fos? As a nuclear protein, IKKa
has been demonstrated to act as a chromatin-associated
kinase that can phosphorylate histone H3 (Ser10) within
the promoter region of NF-kB-responsive genes and con-
tribute largely to the induction of NF-kB transactivation
in response to inﬂammatory stimuli (9,10). Therefore, we
proposed that IKKa might also exert a similar function
for the AP-1-dependent VEGF expression by binding with
c-Fos. To address this hypothesis, a ChIP assay was per-
formed with anti-c-Fos, anti-IKKa and anti-histone
H3-p-Ser10 antibodies. We found that among the ﬁve
motifs homologous to AP-1-reponsive elements within
the mouse vegf promoter, c-Fos could recruit to three
sites, at positions  616 to  606 (Site A),  2121 to
 2115 (Site D) and  2900 to  2892 (Site E), upon
UVB exposure. Under the same conditions, a strong as-
sociation of IKKa to the same chromatin regions was
readily observed (Figure 7F), which was accompanied by
a signiﬁcant enrichment of promoter-bound histone H3
Ser10 phosphorylation (Figure 7G). In the absence of
ikk expression, upregulation of histone H3 Ser10 phos-
phorylation within the vegf promoter was impaired
(Figure 7G). More importantly, without the aid of
c-Fos, IKKa lost the ability to recruit to the vegf
promoter (Figure 7H). In addition, the IKKa deletion
mutant (IKKa-M3) with the defective c-Fos-binding
ability, can only partially rescue the VEGF expression in
the IKKa-null cells compared to its WT counterpart
(Figure 7I), even though this mutant possesses a similar
ability to induce c-Fos expression (Figure 7E) and AP-1
transactivation (data not shown) as the wt IKKa. These
data indicate that IKKa is not only critical for the induc-
tion of the AP-1 component, c-Fos, but can also recruit to
the vegf promoter by binding with c-Fos and trigger the
phosphorylation of promoter-associated histone H3 to fa-
cilitate the AP-1 transactivation in the UVB response
(Figure 7J).
DISCUSSION
UVB irradiation is an important environmental threat to
the skin because it can induce permanent genetic changes
as well as angiogenesis-related skin cancers (1–3). Among
Figure 7. Continued
were transfected with a control vector, WT IKKa or IKKa-NLS expression plasmids, respectively. The cells were subjected to UVB irradiation
(0.5kJ/m
2) 36h after transfection, and the induction of c-Fos phosphorylation and expression were detected at the indicated time points after UVB
exposure. (C) WT MEFs were left untreated or exposed to UVB (0.5kJ/m
2) for 10h. Nuclear extracts were prepared and immunoprecipitated with
an anti-c-Fos antibody or a rabbit IgG, and then the immunoprecipitants were analyzed by a western blot assay with anti-c-Fos, anti-IKKa and
anti-phosphorylated IKKa antibodies. (D) WT IKKa and its deletion mutants were constructed and co-transfected with GFP-c-Fos into 293T cells.
Cell lysate was immunoprecipitated with an anti-GFP antibody, and the immunoprecipitants were analyzed by a western blot assay with an
anti-FLAG antibody to detect the c-Fos-binding ability of the IKKa mutants. (E) IKKa-null cells were transfected with a control vector, WT
IKKa or IKKa-M3 expression plasmids, respectively. The cells were subjected to UVB irradiation (0.5kJ/m
2) 36h after transfection, and the
induction of c-Fos expression was detected at 12h after UVB exposure. (F) Soluble chromatin was prepared from WT MEFs either untreated or
exposed to UVB irradiation (0.5kJ/m
2) for 10h, and then immunoprecipitated with anti-c-Fos and IKKa antibodies, respectively. The DNA
extractions were ampliﬁed with primers that covered the putative AP-1-binding sites (A, D and E) within the mouse vegf promoter or the coding
sequence in the third exon of the vegf gene, which was used as the negative control in this experiment and marked as NC. (G) Soluble chromatin was
prepared from WT and IKKa-null MEFs either untreated or exposed to UVB (0.5kJ/m
2) for 10h, and then immunoprecipitated with an
anti-phospho-histone H3 (Ser10) antibody. The DNA extractions were ampliﬁed with primers that covered the putative AP-1-binding site D
within the mouse vegf promoter. (H) WT MEFs stably transfected with c-Fos shRNA or the control shRNA were either untreated or exposed
to UVB irradiation (0.5kJ/m
2) for 10h. Then the soluble chromatin was prepared and immunoprecipitated with an anti-IKKa antibody. The DNA
extractions were ampliﬁed with primers that covered the putative AP-1-binding site D within the mouse vegf promoter. (I) IKKa-null cells were
transfected with a VEGF promoter-driven luciferase reporter plasmid in combination with a control vector, WT IKKa or IKKa-M3 expression
plasmids, respectively. The cells were subjected to UVB irradiation 36h after transfection, and the VEGF luciferase activities were detected at 24h
after UVB exposure. (J) The proposed model for the action of IKKa in mediating the UVB-induced VEGF expression. IKKa is required for
UVB-induced phosphorylation and accumulation of c-Fos. Moreover, UVB exposure induces the activation of nuclear IKKa, which can recruit to
the vegf promoter regions containing AP-1-binding sites by binding with c-Fos and triggers the phosphorylation of promoter-associated histone H3
to facilitate AP-1 transactivation.
2952 Nucleic Acids Research, 2012,Vol.40, No. 7the various angiogenic growth factors, VEGF is con-
sidered to be key in triggering photodamage-related angio-
genesis and tumorigenesis (4,5). In the current study, we
have focused on the elucidation of the molecular mechan-
isms and the signaling pathway responsible for
UVB-induced VEGF expression in mouse ﬁbroblasts,
one of the major types of stromal cells in the skin. Our
results indicate that IKKa plays a critical role in
mediating VEGF induction via the activation of an
AP-1-dependent pathway in UVB-treated ﬁbroblasts,
which is unrelated to NF-kB and HIF1a activities
(Figures 2–5). In addition, we have also observed the
action of IKKa in mediating AP-1 transactivation and
VEGF expression in UVB-treated mouse epidermal cells
(Figures 2D, 5E and F) and human keratinocytes (data
not shown). Therefore, IKKa might exert a general effect
in regulating VEGF expression through an
AP-1-dependent manner.
IKKa is a multi-functional signaling protein whose
activities can be exerted through a variety of its down-
stream substrates, including NF-kB (9–19). Most of the
recent studies have focused on elucidating the implications
of IKKa, which are unrelated to IKKb, in the control of
the cellular growth properties of both normal and tumor
cells under physiological and pathological conditions. And
the results indicate that IKKa exerts a dual role in the cell
growth control by either promoting cell survival and pro-
liferation or by mediating growth arrest under different
conditions. Therefore, IKKa is regarded as both a
tumor promoter and a tumor suppressor depending on
the cellular growth properties and the downstream
targets that are regulated (7). Aside from these functions,
IKKa is also reported to independently function in re-
stricting inﬂammation by triggering the turnover of p65
and c-Rel or suppressing the DNA-binding ability of p65
in response to inﬂammatory stimuli (14,15). In the current
study, we have disclosed the biological signiﬁcance of
IKKa in mediating the inﬂammatory response by
upregulating VEGF expression upon UVB exposure.
Most importantly, this novel function of IKKa is unre-
lated to the activation status of NF-kB. Taken together,
we anticipate that IKKa might have a more extensive
IKKb-independent role, from cancer to immunity, and
may also function as a dual-regulator for the cellular in-
ﬂammatory response under different stress conditions.
The speciﬁc functions of IKKa in mediating
UVB-induced cell damage effects have been investigated
in our previous studies. The results indicate that IKKa can
mediate both growth arrest and apoptotic response upon
UVB irradiation by regulating cyclin D1 expression (26)
and p53 transactivity (Li, Y. et al., unpublished data),
respectively. These data suggest that IKKa plays an im-
portant role in protecting the cells from UVB-induced
photodamage. In the current study, we have disclosed
the novel function of IKKa in mediating the inﬂammatory
response by modulating VEGF induction. Moreover, the
critical role for IKKa in regulating the production of
another inﬂammatory cytokine, TNFa, upon UVB irradi-
ation was also observed during our recent studies (Li, Y.
et al. unpublished data). Therefore, IKKa seems to also
function as a mediator of UVB-induced inﬂammatory
injury. Based on these data, we conclude that IKKa can
exert multiple roles during the UVB response, including
control of cell growth and survival and mediation of the
inﬂammatory response.
In the study to investigate the molecular mechanisms of
IKKa in mediating UVB-induced VEGF induction, we
found that IKKa-dependent c-Fos induction, transactiva-
tion of AP-1, recruitment of IKKa to the vegf promoter
and phosphorylation of the promoter-associated histone
H3 (Figures 5–7) are the key sequential signaling events
for mediating VEGF expression upon UVB irradiation.
One of the most important steps, the regulation of c-Fos
induction by IKKa, attracted our interest. c-Fos is a
well-known oncoprotein whose expression can be
regulated via transcriptional, post-transcriptional, transla-
tional and post-translational mechanisms (31–35). The ob-
servation that c-fos mRNA transcription was signiﬁcantly
upregulated but its protein expression was impaired in the
UVB-treated IKKa-null cells excluded the possible role
for IKKa in regulating c-fos transcription and mRNA
stability (Figure 6A). Then the accumulation of c-Fos in
the UVB-irradiated IKKa-null cells with MG132 pretreat-
ment demonstrated the critical role for IKKa in prevent-
ing proteasome-dependent degradation of c-Fos in the
UVB response (Figure 6B). It is known that c-Fos
protein stability is greatly increased upon phosphorylation
of the serines and/or threonines located at its N- and
C-termini under various conditions (31,32,36,37). Based
on this information, we found action of IKKa in trigger-
ing N-terminal phosphorylation of c-Fos at Ser32, which
contributes to the increase in c-Fos protein stability upon
UVB irradiation (Figure 6C, D and E). Under the same
conditions, we did not observe phosphorylation of c-Fos
at the C-terminus (data not shown), which had been
shown to contribute largely to the stabilization of c-Fos
by growth factors-induced signals (32). Most importantly,
c-Fos phosphorylation and induction required IKKa
kinase activity and nuclear localization (Figures 6D and
7B) but did not depend on the direct interaction between
IKKa and c-Fos (Figure 7D and E). This conclusion was
based on the IKKa deletion mutant, which has an intact
kinase domain and functional NLS (such as IKKa-M3),
can efﬁciently induce c-Fos expression but has an
impaired ability to bind c-Fos (Figure 7D). According to
these results, we propose that IKKa might indirectly
interact with c-Fos through an unidentiﬁed signaling
molecule, whose activity can be regulated by IKKa and
is responsible for the phosphorylation and expression of
c-Fos in the UVB response. We have noticed that a pre-
viously published report has demonstrated the involve-
ment of ERK5 in c-Fos Ser32 phosphorylation and
stabilization by gp130-dependent signals (31). Whether
ERK5 also participates in IKKa-mediated c-Fos expres-
sion in the cellular UVB response deserves further
investigation.
Due to its nuclear localization and ability to associate
with chromatin, IKKa is regarded as a novel regulator
for gene expression (9,10). It has been well documented
that the nuclear pool of IKKa can trigger the phos-
phorylation of the promoter-bound histone H3, which is
critical for the optimal induction of various genes
Nucleic Acids Research,2012, Vol.40, No. 7 2953including NF-kB-responsive candidates and others, such
as c-Fos in EGF-stimulated cells (9,10,38). However,
whether the recruitment of IKKa to a speciﬁc promoter
region can occur independently or is dependent on
multiple promoter-bound factors, including components
of transcriptional factors or coactivators, has not been
fully clariﬁed. Previous reports have demonstrated that
interactions with the coactivator CBP or SRC3 is
required for the recruitment of IKKa to NF-kB- or
hormone-responsive promoters, respectively (11,39). In
the current study, we have observed the interaction of
IKKa with c-Fos within the nucleus (Figure 7C), which
is critical for the binding of IKKa to the vegf promoter in
response to UVB irradiation (Figure 7H). Notably, the
efﬁciency of IKKa-M3, which has defective c-Fos-
binding abilities, in mediating VEGF expression was par-
tially decreased (Figure 7I). Thus, these data have
provided novel evidence for the chromatin-associated
kinase activity of IKKa in regulating VEGF expression
in the UVB response.
In summary, the data in this study have demonstrated
a novel role and accompanying mechanism of IKKa
in regulating VEGF induction in the cellular UVB
response. Our ﬁndings may help in the understanding of
signaling events that regulate skin angiogenesis following
UVB irradiation and provide a potential clue for prevent-
ing angiogenesis-related skin damage by targeting IKKa.
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